Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: Relationship to the cell-cycle and role of the retinoblastoma protein

Oncogene

Volumn 13, Issue 2, 1996, Pages 373-379

  Wang, Hong ^a   Grand, Roger J A ^a   Milner, Anne E ^a   Armitage, Richard J ^b   Gordon, John ^a   Gregory, Christopher D ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b AMGEN INC   (United States)

Author keywords

Anti Ig; Burkitt lymphoma; Cell survival; Phosphorylation

Indexed keywords

CALCIUM IONOPHORE; CD40 ANTIGEN; IMMUNOGLOBULIN ANTIBODY; IONOMYCIN; PROTEIN BCL 2; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTIBODIES, ANTI-IDIOTYPIC; APOPTOSIS; B-LYMPHOCYTES; BURKITT LYMPHOMA; CD40 LIGAND; CELL CYCLE; G1 PHASE; HUMANS; IONOMYCIN; IONOPHORES; MEMBRANE GLYCOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0029787120     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Askew DS, Ashmun RA, Simmons BC and Cleveland JL. (1991). Oncogene, 6, 1915-1922.
2. Choi MSK, Boise LH, Gottschalk AR, Quintans J, Thompson CB and Klaus GGB. (1995). Eur. J. Immunol., 25, 1352-1357.
3. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature, 362, 849-852.
4. Cuende E, Ales-Martinez JE, Ding LY, Gonzalez-Garcia M, Martineza C and Nunez G. (1993). EMBO J., 12, 1555-1560.
5. Debbas M and White E. (1993). Genes Dev., 7, 546-554.
6. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE and Wyllie AH. (1992). Biochim. Biophvs. Acta., 1133, 275-285.
7. Dou QP, An B and Will PL. (1995). Proc. Natl. Acad. Sci. USA, 92, 9019-9023.
8. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
9. Goodnow CC. (1992). Ann. Rev. Immun., 10, 489-518.
10. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J and Rickinson AB. (1991). Nature, 349, 612-614.
11. Gregory CD and Milner AE. (1994). Int. J. Cancer, 57, 419-426.
12. Gregory CD, Rowe M and Rickinson AB. (1990). J. Gen. Virol., 71, 1481-1495.
13. Harrington EA, Bennett MR, Fanidi A and Evan GI. (1994). EMBO J., 13, 3286-3295.
14. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E and Rickinson A. (1991). Cell, 65, 1107-1115.
15. Hermeking H and Eick D. (1994). Science, 265, 2091-2093.
16. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan ICM, Gregory CD and Gordon J. (1993). Eur. J. Immunol., 23, 2368-2371.
17. Ishida T, Kobayashi N, Tojo T, Ishida S, Yamamoto T and Inoue J. (1995). J. Immunol., 155, 5527-5535.
18. Joseph LF, Ezhevsky S and Scott DW. (1995). Cell Growth Diff., 6, 51-57.
19. Korsmeyer SJ. (1995). Trends in Genetics, 11, 101-105.
20. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J and MacLennan ICM. (1989). Nature, 342, 929-931.
21. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993). Nature, 362, 847-849.
22. Lu YM, Ussery GD, Muncaster MM, Gallie BL and Blanck G. (1994). Oncogene, 9, 1015-1019.
23. MacLennan ICM. (1994). Ann. Rev. Immunol., 12, 117-139.
24. MacDonald I, Wang H, Grand R, Armitage R, Fanslow WC, Gregory CD and Gordon J. (1996). Blood, 87, 1147-1154.
25. Magrath I. (1990). Adv. Cancer Res., 55, 133-270.
26. Maheswaran S, McCormack JE and Sonenshein GE. (1991). Oncogene, 6, 1965-1971.
27. Merino R, Grillot DAM, Simonian PL, Muthukkumar S, Fanslow WC, Bondada S and Nunez G. (1995). J. Immunol., 155, 3830-3838.
28. Milner AE, Grand RJA, Waters CM and Gregory CD. (1993). Oncogene, 8, 3385-3391.
29. Milner AE, Johnson GD and Gregory CD. (1992). Int. J. Cancer, 52, 636-644.
30. Morgenbesser SD, Williams BO, Jacks T and Depinho RA. (1994). Nature, 371, 72-74.
31. Nevins JR. (1992). Science, 258, 424-429.
32. Packham G and Cleveland JL. (1995). Biochim. Biophys. Acta-Reviews On Cancer, 1242, 11-28.
33. Pan HC and Griep AE. (1994). Genes Dev., 8, 1285-1299.
34. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S and White E. (1992). Proc. Natl. Acad. Sci. USA, 89, 7742-7746.
35. Scott DW. (1995). Apoptosis and the Immune Response. Gregory, C.D. (ed.). Wiley-Liss: New York, pp. 187-215.
36. Scott DW, Livnat D, Pennell CA and Keng P. (1986). J. Exp Med., 164, 156-164.
37. Shi L, Nishioka WK, Thng J, Bradbury EM, Litchfield DW and Greenberg AH. (1994). Science, 263, 1143-1145.
38. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T and Van Dyke T. (1994). Cell, 78, 703-711.
39. Tsubata T, Wu J and Honjo T. (1993). Nature, 364, 645-648.
40. Valentine MA and Licciardi KA. (1992). Eur. J. Immunol., 22, 3141-3148.
41. Visvader JE, Elefanty AG, Strasser A and Adams JM. (1992). EMBO J., 11, 4557-4564.
42. Wang JYJ, Knudsen ES and Welch PJ. (1994). Adv. Cancer Res., 64, 25-85.
43. Warner GL, Ludlow JW, Nelson DA, Gaur A and Scott DW. (1992). Cell Growth Diff., 3, 175-181.
44. White AE, Livanos EM and Tlsty TD. (1994). Genes Dev., 8, 666-677.
45. White E, Sabbatini P, Debbas M, Wold WSM, Kusher DI and Gooding LR. (1992). Mol. Cell. Biol., 12, 2570-2580.
46. Wu XW and Levine AJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 3602-3606.
47. Wyllie AH. (1992). Cancer Metastasis Rev., 11, 95-103.
48. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.